Open AccessP1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL‐2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
Author(s) -
Manni S.,
Spinello Z.,
Pesavento M.,
Fregnani A.,
Saggin L.,
Quotti Tubi L.,
Scapinello G.,
Vianello F.,
Zambello R.,
Gurrieri C.,
Semenzato G.,
Trentin L.,
Piazza F.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000847980.27029.cb
Subject(s) - cancer research , ibrutinib , mantle cell lymphoma , protein kinase b , bortezomib , cell growth , venetoclax , pi3k/akt/mtor pathway , bruton's tyrosine kinase , apoptosis , chemistry , biology , pharmacology , lymphoma , signal transduction , tyrosine kinase , immunology , multiple myeloma , microbiology and biotechnology , leukemia , chronic lymphocytic leukemia , biochemistry